Fierce Pharma February 3, 2023
By Max Bayer, Fraiser Kansteiner

J&J’s pharmaceutical changes come as the company spins off its consumer healthcare group into a separate company called Kenvue. (BSR Agency/Getty Images News)

Three Johnson & Johnson pharmaceutical executives stood before a group of staff in the R&D unit Wednesday, joking about expensive Uber rides and one “phenomenal dinner” at a Japanese steakhouse while attending the J.P. Morgan Healthcare Conference in San Francisco in early January.

But just minutes earlier, the mood was anything but jovial, as the leaders explained to a nervous group of employees in the Janssen pharmaceutical unit an overhaul of operations for the infectious diseases and vaccine groups, with sweeping layoffs expected to claim staffers’ jobs in countries around the world. Some staff...

Today's Sponsors


Today's Sponsor


Topics: Biotechnology, Pharma, Pharma / Biotech
The New Radiopharma Competition Requires Unprecedented Medical Logistics
A Wearable Tech Gives Pharmas & Therapists Better Feel for Changes in Mental Health
Jennifer Doudna: The Exciting Future of Genome Editing
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Delirium and Dementia; Are Biosimilars Cheaper for Patients?

Share This Article